Braskem SA reported a consolidated recurring EBITDA of $150 million for Q3 2025, a 104% increase from Q2 2025, while facing lower resin sales but an 11% growth in main chemical sales in Brazil. The company continues to address legal and operational challenges stemming from a geological event in Alagoas, with a total provision of R$3.8 billion.